Abu Dhabi researchers hopeful of Type 1 diabetes breakthrough within two years
Researchers at the Abu Dhabi Stem Cells Centre are hopeful of a breakthrough in their work on a cure for Type 1 diabetes 'in the next couple of years'. The most promising development is focused on regenerating the pancreas using stem cells and is part of a collaboration with Kyoto University and research company Rege Nephro. In Type 1 diabetes, the pancreas progressively reduces the amount of insulin (the hormone that regulates blood glucose levels) it produces until it stops producing any at all. If glucose in the blood is too high, it can seriously damage the body's organs. It is hoped pancreas regeneration can reverse this process. 'We're very optimistic that in the next couple of years, we'll have something solid to offer patients,' Prof Yendry Ventura, the centre's chief executive, said. 'This isn't just stem cell therapy – it's an approach to regenerate the pancreas itself using a specific type of engineered cell.' The process is still in the pre-clinical stage but hopes remain high. Research and development 'takes time', Prof Ventura added. 'You need to stabilise a strong cell line, trial it in the lab, test it on animals and only then can you move into human trials. Right now, we're preparing to begin animal testing, after extensive lab work with our Japanese partners.' The work is being showcased at Expo 2025 in Osaka, Japan. The fair provides an opportunity to highlight the centre's scientific achievements and the UAE's growing presence in cutting-edge health care, Prof Ventura said. 'We're using Osaka Expo as a platform to present the progress we've made with our partners Kyoto University and [biotech firm] Rege Nephro,' he added. 'It's also a chance to showcase what we've built in Abu Dhabi and how we're working alongside some of the world's most respected institutions.' Though ADSCC has collaborative relationships, it handles its own cell production and storage. 'We have our own infrastructure. Cells intended for therapies need special storage conditions,' Prof Ventura said. 'There's a difference between storing tissue for studies and storing it for treatment purposes.' He said the UAE's capabilities complement those of its international partners. 'We're focused on developing specific stem cells that can later become any kind of tissue. That's different from just storing samples, but the two approaches work hand in hand.' The project is being developed in close co-operation with Kyoto University's Centre for iPS Cell Research and Application. 'Their contribution has given us access to expertise and speed,' said Prof Ventura. 'At the same time, the UAE is emerging as a leader in stem cell research across the region.' ADSCC is not new to breakthroughs in this area. In January, the centre announced the successful treatment of a 20-year-old Emirati patient with Type 1 diabetes, using umbilical cord-derived mesenchymal stem cells. The procedure, developed and carried out entirely at ADSCC, resulted in significantly improved blood sugar levels and a drop in diabetes-related antibodies within one month of treatment. The treatment is a major step forward in using regenerative medicine to manage diabetes. Regenerative medicine focuses on the body's ability to heal itself at cellular and organ levels. It includes treatments that use stem cells, engineered tissues and even bio-manufactured organs to restore or replace damaged parts of the body. Mesenchymal stem cells, known for their ability to modulate immune responses and repair tissue, are gaining attention as a possible way to restore pancreatic function and reduce complications in diabetic patients. 'Being able to do this entirely in the UAE, using cells produced locally, is a milestone for us,' Prof Ventura said. The country's participation at the expo in Japan reflects a broader national commitment to innovation in health care, said Dr Fatima Al Kaabi, executive director of the Abu Dhabi Bone Marrow Transplant Programme. 'We're a young centre, only six years since inception, but we're already standing alongside global leaders,' she said. 'It's an honour to represent the UAE and show our standards meet the highest benchmarks.' She highlighted the power of pluripotent stem cells, which have the ability to turn into almost any type of tissue. 'Whether it's heart, liver, brain or pancreas, these cells hold incredible potential. The challenge now is to harness that potential and find real solutions to some of the world's most devastating diseases.' Dr Al Kaabi said regenerative medicine is not only the future of health care, it's already reshaping how doctors approach treatment. 'If we can unlock what these cells can do, we can transform the way we treat cancer, autoimmune conditions and traumatic injuries. With the vision and talent we have at ADSCC, I believe we're on the right path.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
8 hours ago
- Khaleej Times
No more insulin injections for diabetes patients? UAE doctors explain cell-based treatment
Many diabetic patients abroad have said goodbye to insulin injections or now use them less frequently and in lower doses, according to doctors who noted patients recovered after undergoing a simple surgical procedure to transplant pancreatic cells. "50 per cent of patients with Type 1 diabetes — who typically rely on insulin injections — have been cured through 'islet cell transplantation'," Dr Tahra Abdalla Al Ali, a pediatrician based in the UAE, told Khaleej Times. "This has cured people of their pancreas's inability to produce insulin. Patients will no longer depend on insulin as they look forward to a future without constant insulin management.' Dr Al Ali noted, 'In 25 cases, pancreatic cells were transplanted; and the success rate for this group was 85 per cent. Of the patients, 50 per cent completely stopped using medication. The remaining group members use injections at lower doses and less frequently.' Stay up to date with the latest news. Follow KT on WhatsApp Channels. This treatment, which aims to benefit all patient groups, initially targeted individuals over the age of 20 who suffered from complications of diabetes and had difficulty maintaining healthy levels for an extended period. Procedure explained Dr Al Ali said islet cell transplantation involves transplanting pancreatic cells extracted from donors and studying them in specialised laboratories. Once the safety of these samples is confirmed, they are injected into the patient using a catheter-like method through the skin into a vein and then transplanted onto the liver. 'The transplanted cells help restore and regulate blood sugar levels in patients with type 1 diabetes, preventing severe, life-threatening hypoglycemia episodes and allowing patients to eliminate their daily insulin injections,' she added. Simple and safe The procedure is considered an alternative to the complete pancreas transplant to avoid surgical complications, including organ rejection and bleeding. It is regarded as a safe and simple treatment method. The Emirates Health Services (EHS), in collaboration with the University of Chicago, is working to treat patients from the UAE either abroad or by bringing experts to the country to provide care. Only for Type 1 diabetes The procedure is used exclusively for patients with Type 1 diabetes, where the main issue is the destruction of insulin-producing beta cells, Dr Patanjali Panduranga, endocrinologist at Aster Hospital, explained. It is not considered a treatment for Type 2 diabetes, where insulin resistance is the primary problem. However, some early studies are exploring its use in selected cases of insulin-dependent type 2 diabetes, although this remains under investigation. He noted the US Food and Drug Administration (FDA) approved islet cell transplantation in 2023 for adults with Type 1 diabetes who experienced severe hypoglycemia or poor glucose control despite intensive insulin therapy. Limitations remain 'Although the procedure has shown promising results, including insulin independence in up to 50 per cent of recipients, its broader clinical use remains limited due to the need for lifelong immunosuppression and the scarcity of suitable donor cells,' said Dr Panduranga. Dr Arvind Gaddameedi, another endocrinologist at Aster Clinic, explained that the success of islet cell transplantation depends on two key factors, safety and sustainability. Unlike full organ transplants, this procedure involves a 30-minute infusion under local anesthesia, making it accessible even to high-risk patients. However, challenges remain. One of the challenges is the availability of donor cells. While organ donation rates vary globally, innovations in islet cell processing, cryopreservation, and even stem cell-derived islets, currently under trial, may soon expand accessibility. 'These developments represent a new dawn in diabetes care. While not yet a first-line treatment, islet cell transplantation is a vital option for patients struggling with the demands of insulin therapy. As research progresses, improvements in immunosuppression, donor matching, and cell supply are expected to make this treatment more widely available.'
The National
9 hours ago
- The National
Oceans face unprecedented challenges, says UAE Climate Minister
The health of the world's oceans is at serious risk warned Dr Amna Al Dahak, Minister of Climate Change and Environment. The minister was making her comments on World Oceans Day, June 8. The UAE is committed to protecting ocean ecosystems and enhancing their sustainability as a vital resource at both the national and global levels, she was quoted by state news agency Wam as saying. 'Covering more than 70 per cent of the Earth's surface, our oceans are undeniably essential to human lives and livelihoods,' said Dr Al Dahak. 'They are the lifeblood of our planet, regulating our climate, providing sustenance, and supporting countless ecosystems. 'We recognise, however, that our oceans face unprecedented challenges. From the impacts of climate change, evidenced by coral bleaching and rising sea levels, to the pressures of unsustainable fishing practices, the health of our oceans is at risk.' The UN has said that urgent action needs to be taken to address the harm being done to oceans, with 90 per cent of big fish populations depleted, and 50 per cent of coral reefs destroyed. Earlier this year, The National reported how Sylvia Earle, one of the world's most famous oceanographers and marine biologists, had raised the alarm over the threat posed to ocean ecosystems by climate change and overfishing. She said the world is 'perilously close' to tipping the balance of ocean life. 'As a nation deeply connected to the sea, we understand the urgency of these challenges and are committed to leading the way in finding solutions,' said Dr Al Dahak. 'We recognise the responsibility we have to safeguard these resources for future generations, and we are actively implementing strategies to mitigate these threats and restore the health of our marine ecosystems.' The UN states the ocean is key to the global economy with an estimated 40 million people being employed by ocean-based industries by 2030. Oceans also produce at least 50 per cent of the planet's oxygen. They also absorb about 30 per cent of carbon dioxide produced by humans, buffering the impacts of global warming. Dr Al Dahak highlighted the efforts being made by the UAE as examples of its commitment to tackling the issue both regionally and globally. 'Our efforts in mangrove preservation and coral rehabilitation have been highly successful. Work is under way on our coral rehabilitation project to outplant more than four million coral colonies in the emirate's waters by 2030,' she said. 'We are also working to achieve our 100 million mangrove plantation target by 2030. These are goals that we must all work together to achieve. 'Our commitment extends beyond our national waters. The UAE is proud to be the first nation in the Middle East to join the 100 Per Cent Alliance, a UN initiative by the High-Level Panel for a Sustainable Ocean Economy, calling on coastal states to commit to sustainable management of all ocean areas under their jurisdiction.'
The National
a day ago
- The National
UAE floating hospital brings Eid joy to Gaza patients
The UAE floating hospital in the Egyptian city of Al Arish held an event for children and patients from Gaza to mark Eid Al Adha, offering a moment of relief and celebration amid the trauma of war. Organised by medical staff, volunteers and support teams, the event featured face painting, games and the distribution of Eid gifts to patients and their families. The initiative aimed to provide psychological support, rehabilitative therapy and lift the spirits of those receiving care aboard the hospital vessel. 'The initiative is a testament to the hospital's humanitarian message to boost morality and happiness for patients and their families onboard of the vessel,' said Dr Omran Mohammed Alefari, director of the UAE floating hospital. 'It is important to provide a comprehensive medical and supportive environment for the patients, especially in such days.' The 100-bed floating hospital set sail from the UAE in February last year and docked in Al Arish port in Egypt as part of Operation Gallant Knight 3. Docked at the Egyptian port of Al Arish, it receives patients through the Rafah border crossing and is part of the broader humanitarian effort ordered by UAE President Sheikh Mohamed - serving as a lifeline for Palestinians affected by the conflict. Its humanitarian efforts are part of the UAE's mission to ease the suffering of the injured and sick amid the dire circumstances faced by Palestinians in Gaza. The hospital has provided medical services to thousands of patients since the launch of its services for Palestinian people. It has also performed more than 3,600 surgical procedures across specialities, provided physical therapy services to approximately 9,500 cases and fitted 23 prosthetic limbs for patients. The hospital was established by the UAE's Ministry of Defence, the Department of Health Abu Dhabi and the Abu Dhabi Ports Authority group, and includes about 100 medical and administrative staff specialising in anaesthesia, general surgery, orthopaedics and emergency services.
